---
schema_version: "secwatch.filing_event.v1"
accession: "0001356576-26-000007"
form_type: "8-K"
ticker: "SUPN"
cik: "0001356576"
company_name: "SUPERNUS PHARMACEUTICALS, INC."
filed_at: "2026-02-24T23:59:59+00:00"
generated_at: "2026-05-16T00:45:03.793824+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Supernus raises CEO salary to $1.067M, awards $847K bonus and equity grants

## Summary
- CEO salary increased to $1,067,100 from $1,036,000; 2025 bonus $846,930.
- CEO granted options for 341,610 shares and 204,966 PSUs at $50.20 strike.
- CFO salary raised to $525,100 from $504,900; 2025 bonus $233,894.
- CFO gets 17,500 options, 3,000 RSUs, and 3,500 PSUs.
- Three other execs (Bhatt, Rubin, Mottola) also received salary increases and equity.

## SEC filing metadata
- accession: 0001356576-26-000007
- form_type: 8-K
- ticker: SUPN
- cik: 0001356576
- company_name: SUPERNUS PHARMACEUTICALS, INC.
- filed_at: 2026-02-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1356576/000135657626000007/0001356576-26-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1356576/000135657626000007/supn-20260224.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001356576-26-000007
- JSON: https://secwatch.observer/filing/0001356576-26-000007.json
- Plain text: https://secwatch.observer/filing/0001356576-26-000007.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.